PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.\', \'Department of Internal Medicine I, Ulm University Medical Center, Ulm, Germany.\', \'Department of Infectious Diseases, King\'s College London, London, UK.\', \'Department of Internal Medicine II (Cardiology), Ulm University, Ulm, Germany.\', \'Core Facility of Functional Peptidomics, Ulm University Medical Center, Ulm, Germany.\', \'Core Unit of Mass Spectrometry and Proteomics, Ulm University Medical Center, Ulm, Germany.\', \'Institute of Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.\', \'Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.\', \'Institute for Anatomy and Cell Biology, Ulm University, Ulm, Germany.\', \'Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm University, Ulm, Germany.\', \'Institute of Medical Microbiology and Hygiene, Ulm University Medical Center, Ulm, Germany.\', \'Institute of Medical Science, The University of Tokyo, Tokyo, Japan.\', \'Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. Konstantin.Sparrer@uni-ulm.de.\', \'Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany. Frank.Kirchhoff@uni-ulm.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41467-021-24817-y
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 34321474
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all